2014
DOI: 10.1016/j.bios.2014.01.006
|View full text |Cite
|
Sign up to set email alerts
|

Simultaneous electrochemical detection of multiple tumor markers using metal ions tagged immunocolloidal gold

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
27
0
1

Year Published

2015
2015
2020
2020

Publication Types

Select...
7
1
1

Relationship

2
7

Authors

Journals

citations
Cited by 98 publications
(28 citation statements)
references
References 30 publications
0
27
0
1
Order By: Relevance
“…Electrochemical analysis has the advantages of high sensitivity, compatibility for miniaturization, easy operation and low cost, making it an attractive candidate for two biomarkers testing systems (Wang, 2002;Lee and Hsing, 2006). However, the vast majority of reports are concerned with the detection of only single analyte (for Lys, Jing et al, 2010;Subramanian et al, 2013;Lian et al, 2014;Erdema et al, 2014;for IFN-γ, Chang et al, 2012;Chen et al, 2014;Zhang et al, 2012;Zhao et al, 2012;Jiang et al, Xu et al (2014) proposed a sandwitch-format electrochemical immunosensor for the simultaneous detection of two tumor markers (carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP)). Qi et al (2012) developed an electrochemical immunoassay array for the simultaneous detection of CEA and AFP by incorporating electrochemically addressing immobilization and one signal antibody strategy.…”
Section: Introductionmentioning
confidence: 96%
“…Electrochemical analysis has the advantages of high sensitivity, compatibility for miniaturization, easy operation and low cost, making it an attractive candidate for two biomarkers testing systems (Wang, 2002;Lee and Hsing, 2006). However, the vast majority of reports are concerned with the detection of only single analyte (for Lys, Jing et al, 2010;Subramanian et al, 2013;Lian et al, 2014;Erdema et al, 2014;for IFN-γ, Chang et al, 2012;Chen et al, 2014;Zhang et al, 2012;Zhao et al, 2012;Jiang et al, Xu et al (2014) proposed a sandwitch-format electrochemical immunosensor for the simultaneous detection of two tumor markers (carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP)). Qi et al (2012) developed an electrochemical immunoassay array for the simultaneous detection of CEA and AFP by incorporating electrochemically addressing immobilization and one signal antibody strategy.…”
Section: Introductionmentioning
confidence: 96%
“…AuNPs have excellent electrical conductivity and biocompatibility, which can be used as immunoprobe carrier for simultaneous multianalyte detection [55]. The multiplexed immunoassay exhibited good sensitivity and selectivity for the simultaneous determination of CEA and AFP with linear ranges of 0.01-50 ng ml À1 and detection limits 4.6 and 3.1 pg ml À1 , respectively.…”
Section: Immunoprobesmentioning
confidence: 96%
“…HRP-hollow Pt nanoparticles CEA: 50.0 AFP: 80.0 CEA: 0.5-50 AFP: 0.3-45 [52] HRP and GOD/graphene-Pt CEA: 1.64 AFP: 1.33 CEA: 0.01-100 AFP: 0.01-100 [53] AuNPs CEA: 4.6 AFP: 3.1 CEA: 0.01-50 AFP: 0.01-50 [55] Hollow gold nanosphere CEA: 1.0 AFP: 1.0 CEA: 0.01-80 AFP: 0.01-200 [56] Platinum porous nanoparticles CEA: 2.0 AFP: 50.0 CEA: 0.05-200 AFP: 0.05-200 [57] PtPd nanocage CEA: 1.4 AFP: 1.0 CEA: 0.05-200 AFP: 0.03-100 [58] Redox probe modified rGO CEA: 3.0 AFP: 2.0 CEA: 0.01-100 AFP: 0.01-100 [61] Cyclodextrin-modified graphene CEA: 0.5 AFP: 0.8 CEA: 0.003-40 AFP: 0.001-60 [62] Onion-like mesoporous graphene PSA: 3.4 fPSA: 6.7 PSA: 0.02-10 fPSA: 0.01-50 [63] AuNPs-carbon nanotubes AFP: 8. prepared by large number of HRP-and GOD-loaded graphene-platinum nanocomposites as immunoprobe carrier [53]. The sensitivity of immunosensor was greatly amplified because of excellent catalytic performance to glucose and H 2 O 2 .…”
Section: Immunoprobesmentioning
confidence: 99%
“…Various approaches have been proposed to perform simultaneous detection of multiple tumor markers in the past few years. For example, electrochemical immunoassay (Wilson, 2007;Xu et al, 2014), label-free methods (Lin et al, 2011;Kong et al, 2013), dielectrophoresi assays (Lee et al, 2010;Ramón-Azcón et al, 2011), chemiluminescence alalysis (Zong et al, 2012;Guo et al, 2013), biobarcoded Scanometric assay (Stoeva et al, 2006), spectrometry (Chon et al, 2011;Giesen et al, 2011), fluorescence detection (Tian et al, 2012;Akinfieva et al, 2013), photonic suspension array (Zhao et al, 2009). But all these techniques are not suitable for point-of-care testing because they require large and sophisticated instruments, complex operations, long analysis time and highly skilled personnel to manipulate.…”
Section: Introductionmentioning
confidence: 97%